Members |
targetComponentId |
10*9 Platelets/liter |
10^9 platelets/liter (qualifier value) |
10*9 cells/L |
10^9 cells/L |
10*9/liter |
10^9/L |
10-30% body burnt |
Burn any degree involving 10-19 percent of body surface |
10-30% body burnt |
Burn any degree involving 20-29 percent of body surface |
10-30% body burnt |
Burn any degree involving 20-29 percent of body surface |
10-30% body burnt |
Burn any degree involving 30-39 percent of body surface |
10-30% body burnt |
Burn any degree involving 10-19 percent of body surface |
10-30% body burnt |
Burn any degree involving 30-39 percent of body surface |
11-hydroxyetiocholanolone |
11-hydroxyandrosterone (substance) |
15 year examination |
Child 15 year examination (procedure) |
15 year examination |
Child 15 year examination (procedure) |
15 year examination |
Child 15 year examination (procedure) |
16-dehydroprogesterone hydratase |
16-alpha-hydroxyprogesterone dehydratase |
17-Beta-estriol |
Estradiol |
18-Hydroxydeoxycortisol measurement |
18-Hydroxycortisol measurement |
1q partial trisomy syndrome |
Partial trisomy of long arm of chromosome 1 (disorder) |
1q partial trisomy syndrome |
Trisomy 1q is a rare chromosomal anomaly syndrome, resulting from the partial duplication of the long arm of chromosome 1, with a highly variable phenotype principally characterized by intellectual disability, short stature, craniofacial dysmorphism (including macro/microcephaly, prominent forehead, posteriorly rotated, low-set ears, abnormal palpebral fissures, microphthalmia, broad, flat nasal bridge, high-arched palate, micro/retrognathia), cardiac defects and urogenital anomalies. Patients may also present cerebral (e.g. ventriculomegaly) and gastrointestinal malformations, as well as dystonic tremor and recurrent respiratory tract infections. |
2,2-Dichloro-1,1-difluoroethylmethyl ether |
Methoxyflurane |
2-Thio,4-Carboxythiazolidine |
2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid |
2-Thio,4-carboxythiazolidine measurement |
2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid measurement (procedure) |
21q partial trisomy syndrome |
21q partial trisomy (disorder) |
21q partial trisomy syndrome |
21q partial distal trisomy (disorder) |
22q11 microdeletion with complete DiGeorge sequence |
A rare chromosomal anomaly which causes a congenital malformation disorder that is typically characterized by cardiac defects, palatal anomalies, facial dysmorphism, developmental delay and immune deficiency. |
24 hour urine volume (& level) |
24 hour urine sample volume measurement |
24 hour urine volume (& level) |
Finding of 24 hour urine volume (finding) |
3 Buck shot, device |
Shotgun shot |
3 Buck shot, device |
Shot size |
3 day faecal fat estimation (& level) |
3 day faecal fat estimation |
3,4 Methylhippurate |
Para-methyl hippurate (substance) |
3,4-Methylhippurate measurement |
para-Methyl hippurate measurement (procedure) |
3-Hydroxybutylcarnitine |
3-hydroxybutyrylcarnitine (substance) |
3-Hydroxybutylcarnitine measurement |
3-hydroxybutyrylcarnitine measurement |
3-tree-Pharmacia pollen mix |
Tree pollen (substance) |
3-tree-Pharmacia pollen mix allergen |
Tree pollen (substance) |
3/4 crown |
Crown |
30-50% body burnt |
Burn any degree involving 50-59 percent of body surface |
30-50% body burnt |
Burn any degree involving 40-49 percent of body surface |
30-50% body burnt |
Burn any degree involving 50-59 percent of body surface |
30-50% body burnt |
Burn any degree involving 30-39 percent of body surface |
30-50% body burnt |
Burn any degree involving 30-39 percent of body surface |
30-50% body burnt |
Burn any degree involving 40-49 percent of body surface |
4 Buck shot, device |
Shot size |
4 Buck shot, device |
Shotgun shot |
4,5-Dihydroxyhexanolactone |
4,5-dihydroxyhexanoate (substance) |
4-Allylmethoxy-2-phenol |
Eugenol |
4-Hydroxyphenylpyruvate dioxygenase deficiency |
4-Hydroxyphenylpyruvate dioxygenase deficiency (disorder) |
4-Hydroxyphenylpyruvate dioxygenase deficiency |
Tyrosinemia type III (disorder) |
4-Hydroxyphenylpyruvate dioxygenase deficiency |
Hawkinsinuria (disorder) |
4-quinolones overdose |
Quinolone antibacterial overdose |
4-quinolones overdose of undetermined intent |
Quinolone antibacterial overdose |
4-quinolones poisoning |
Fluoroquinolone poisoning (disorder) |
4-quinolones poisoning of undetermined intent |
Fluoroquinolone poisoning (disorder) |
5-OH indole acetic acid (& level (& urine)) |
5-hydroxyindole acetic acid (substance) |
5-OH indole acetic acid (& level (& urine)) |
5-Hydroxyindoleacetic acid measurement, quantitative, urine |
5-OH indole acetic acid (& level (& urine)) |
5-hydroxyindole acetic acid (substance) |
5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water) |
5-chloro-2-methyl-4-isothiazolin-3-one (substance) |
5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water) |
2-methyl-4-isothiazolin-3-one |
50-70% body burnt |
Burn any degree involving 50-59 percent of body surface |
50-70% body burnt |
Burn any degree involving 60-69 percent of body surface |
50-70% body burnt |
Burn any degree involving 50-59 percent of body surface |
50-70% body burnt |
Burn any degree involving 70-79 percent of body surface |
50-70% body burnt |
Burn any degree involving 70-79 percent of body surface |
50-70% body burnt |
Burn any degree involving 60-69 percent of body surface |
6 mm caliber bullet, device |
Bullet |
mélange de pollen de six graminées de Pharmacia |
Grass pollen |
6-grass Pharmacia pollen mix allergen |
Grass pollen |
6.5 mm caliber bullet, device |
Bullet |
60-80% of predicted peak flow rate (& expiratory) |
60 to 80 percent of predicted peak expiratory flow rate |
7 mm caliber bullet, device |
Bullet |
7/8 crown |
Crown |
8 mm caliber bullet, device |
Bullet |
8p partial trisomy syndrome |
Partial trisomy of short arm of chromosome 8 |
8p partial trisomy syndrome |
Trisomy 8p is a rare chromosomal anomaly syndrome, resulting from the partial duplication of the short arm of chromosome 8, with highly variable phenotype ranging from no dysmorphic features and only mild intellectual disability to patients with severe developmental delay, neonatal hypotonia, short stature, profound intellectual disability, mild dysmorphic features (e.g. mild ptosis, hypertelorism, down-slanting palpebral fissures, broad nasal bridge, short, prominent philtrum, abnormal dentition) and structural brain abnormalities. Autism, epilepsy, and spastic paraplegia have also been reported. |
9 mm caliber bullet, device |
Bullet |
9p partial monosomy syndrome |
Monosomy 9p is a rare chromosomal anomaly characterized by psychomotor developmental delay, facial dysmorphism (trigonocephaly, midface hypoplasia, upslanting palpebral fissures, dysplastic small ears, flat nasal bridge with anteverted nostrils and long philtrum, micrognathia, choanal atresia, short neck), single umbilical artery, omphalocele, inguinal or umbilical hernia, genital abnormalities (hypospadia, cryptorchidism), muscular hypotonia and scoliosis. |
A |
Abdominal lymph node tumor invasion status A (tumor staging) |
A |
Upper case Roman letter A (qualifier value) |
A/B cover need - surg./dentist |
Requires antibiotic coverage for surgical procedure (finding) |
A/B cover need - surg./dentist |
Requires antibiotic coverage for dental procedure |
A/B cover need - surgery &/or dentist |
Requires antibiotic coverage for surgical procedure (finding) |
A/B cover need - surgery &/or dentist |
Requires antibiotic coverage for surgical procedure (finding) |
A/B cover need - surgery &/or dentist |
Requires antibiotic coverage for dental procedure |
A/B cover need - surgery &/or dentist |
Requires antibiotic coverage for dental procedure |
A/N U/S scan for ? abnormality |
Antenatal ultrasound scan for possible abnormality (procedure) |
A/N U/S scan normal +? dates |
Antenatal ultrasound scan normal and possibly inconsistent with estimated date of delivery (finding) |
A/N amnio. for ? chrom.abnorm. |
Amniocentesis for possible chromosomal abnormality (procedure) |
A/N amnio. for ? neural tube |
Amniocentesis for possible neural tube defect (procedure) |
AA amyloidosis |
AA amyloidosis |
ACE inhibitor-aggravated angioedema-urticaria (disorder) |
ACE inhibitor-aggravated angioedema |
ACTH deficiency |
ACTH deficiency |
ACTH deficiency |
Isolated corticotropin deficiency |
AD type amyloidosis |
Amyloidosis of skin |
AD type amyloidosis |
Senile brain amyloidosis |
AIDS with Burkitt's tumor |
Burkitt lymphoma co-occurrent with human immunodeficiency virus infection (disorder) |
AIDS with CNS demyelinating disease |
Central nervous system demyelinating disease with acquired immunodeficiency syndrome (disorder) |
AIDS with Kaposi's sarcoma |
Kaposi's sarcoma with AIDS (acquired immunodeficiency syndrome) |
AIDS with Nocardia infection |
Nocardiosis with acquired immunodeficiency syndrome (disorder) |
AIDS with abnormal weight loss |
Abnormal weight loss associated with AIDS |
AIDS with acquired hemolytic anemia |
Acquired haemolytic anaemia associated with AIDS |
AIDS with acute endocarditis |
Acute endocarditis with AIDS (acquired immunodeficiency syndrome) |